Ensysce Biosciences, Inc. (ENSC) vs Exicure, Inc. (XCUR)
Ensysce Biosciences, Inc. and Exicure, Inc. are both Biotechnology companies. Ensysce Biosciences, Inc. and Exicure, Inc. are of similar size ($8.1M and $7.8M). Exicure, Inc. grew revenue faster over the last twelve months: 2,366.5% against −39.3%. Exicure, Inc. has the higher net margin (0.00% vs −280.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Exicure, Inc. leads on 12 and Ensysce Biosciences, Inc. on 3.
Valuation
Profitability
| Metric | ENSC | XCUR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 80.08% | 65.16% |
| Operating margin | (281.32%) | 0.00% | 0.00% |
| Net margin | (280.49%) | 0.00% | 0.00% |
| Free cash flow margin | (196.76%) | 0.00% | 0.00% |
| Return on equity | (1,295.01%) | (168.37%) | (57.72%) |
| Return on assets | (295.92%) | (54.98%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack